NCT03479723Completed
Identification of Predictors for Coronary Plaque Erosion in Patients With Acute Coronary Syndrome
Source: ClinicalTrials.gov · Last updated 29 Dec 2025
Brief summary (registry, in English)
The purpose of this study is to perform pooled analysis with data collected from 5 previously published studies and 8 unpublished datasets collected from international sites. The main goal of this study is to identify the predictors of plaque erosion.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 1793 (actual)
- First submitted
- 14 Mar 2018
- Start date
- 1 Dec 2017
- Primary completion date
- 1 Dec 2019
- Lead sponsor
- Massachusetts General Hospital
- Diseases
- Coronary artery disease
- NCT number
- NCT03479723
What you commit to
- Study type: Observational
- Participants enrolled: 1793
- From 1 Dec 2017 to the primary completion date, 1 Dec 2019
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- None
Who the study is looking for
- Diagnosed with ACS upon admission to hospital, including patients with ST-elevation myocardial infarction (STEMI), non-ST elevation myocardial infarction (NSTEMI), and unstable angina pectoris (UAP).
- Intra-vascular OCT imaging of culprit vessel.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Massachusetts General Hospital Coordinator of this site? Confirm its status | Boston | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.